Frontiers in Pharmacology | Neuropharmacology

Correction

Published on 29 Jan 2025

Corrigendum: Polydatin ameliorates early brain injury after subarachnoid hemorrhage through up-regulating SIRT1 to suppress endoplasmic reticulum stress

in Neuropharmacology

Yuwei Han
Guangzhi Hao
Song Han
Tingzhun Zhu
Yushu Dong
Ligang Chen
Xinyu Yang
Xiaoming Li
Hai Jin
Guobiao Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1537295

577 views

Review

Published on 27 Jan 2025

Trends in research on novel antidepressant treatments

in Neuropharmacology

Agnieszka Zelek-Molik
Ewa Litwa

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1544795

2,066 views
1 citation

Original Research

Published on 27 Jan 2025

Enhanced bioavailability of Quercetin-loaded niosomal in situ gel for the management of Parkinson’s disease

in Neuropharmacology

Abhishek A. Revankar
Archana S. Patil
Reshma Karishetti
Krutuja R. Chougule
Priyanka Patil
Abhijit Salokhe

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1519649

949 views

Original Research

Published on 27 Jan 2025

Following intravenous thrombolysis, the outcome of diabetes mellitus associated with acute ischemic stroke was predicted via machine learning

in Neuropharmacology

Xiaoqing Liu
Miaoran Wang
Rui Wen
Haoyue Zhu
Ying Xiao
Qian He
Yangdi Shi
Zhe Hong
Bing Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1506771

793 views

Original Research

Published on 23 Jan 2025

αAsarone alleviates neuronal injury by facilitating autophagy via miR-499-5p/PDCD4/ATG5 signaling pathway in ischemia stroke

in Neuropharmacology

Yonghuan Yan
Linfang Wu
Lu Wang
Dandan Wang
Mengting Huang
Jinyong Peng
Yingying Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1504683

1,040 views

Original Research

Published on 23 Jan 2025

Trazodone effectiveness in depression: impacts of trazodone extended release vs SSRIs on the health status and quality of life of patients with major depressive disorder

in Neuropharmacology

Marcin Siwek
Adrian Andrzej Chrobak
Anna Julia Krupa
Aleksandra Gorostowicz
Andrzej Juryk
Dominika Dudek

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1525498

1,153 views

Original Research

Published on 23 Jan 2025

Real-world pharmacovigilance of ofatumumab in multiple sclerosis: a comprehensive FAERS data analysis

in Neuropharmacology

Hui Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1521726

1,759 views

Mini Review

Published on 23 Jan 2025

A ketogenic diet regulates microglial activation to treat drug addiction

in Neuropharmacology

Jie Ji
Yi Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1462699

1,550 views

Original Research

Published on 22 Jan 2025

Pirfenidone regulates seizures through the HMGB1/TLR4 axis to improve cognitive functions and modulate oxidative stress and neurotransmitters in PTZ-induced kindling in mice

in Neuropharmacology

Mansi Dahalia
Sparsh Gupta
Haya Majid
Divya Vohora
Nidhi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1528032

1,486 views
1 citation

Original Research

Published on 22 Jan 2025

Effect of β-blocker on clinical outcomes in patients with traumatic brain injury: a retrospective propensity-matched study

in Neuropharmacology

Yaxin Zhang
Tingting Liu
Wenwen Ji
Guangdong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1465657

768 views

Original Research

Published on 20 Jan 2025

Design, synthesis, and anti-inflammatory activity of 2H-1,4-benzoxazin-3(4H)-one derivatives modified with 1,2,3-triazole in LPS-induced BV-2 cells

in Neuropharmacology

Xixi Hou
Longfei Mao
Huibin Zhang
Lan Wang
Baoyu He
Jingjing Guo
Jianji Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1509520

837 views

Review

Published on 15 Jan 2025

Apelin/APJ system: a novel promising target for anti-oxidative stress in stroke

in Neuropharmacology

Weilin Xu
Jun Yan
Zachary D. Travis
Cameron Lenahan
Liansheng Gao
Haijian Wu
Jingwei Zheng
Jianmin Zhang
Anwen Shao
Jun Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1352927

763 views

Case Report

Published on 15 Jan 2025

Case Report: Targeted treatment by fluoxetine/norfluoxetine of a KCNC2 variant causing developmental and epileptic encephalopathy

in Neuropharmacology

Ping Li
Alice Butler
Yu Zhou
Karl L. Magleby
Christina A. Gurnett
Lawrence Salkoff

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1528541

1,400 views

Original Research

Published on 09 Jan 2025

Protective effects of berbamine against arginase-1 deficiency-induced injury in human brain microvascular endothelial cells

in Neuropharmacology

Xiaolan Wei
Weiwei Li
Zixuan Chen
Jintu Chen
Yun Chen
Jiangping Cai
Huasong Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1497973

763 views

Systematic Review

Published on 09 Jan 2025

Multi-omics approaches to deciphering complex pathological mechanisms of migraine: a systematic review

in Neuropharmacology

Jiaojiao Liu
Qiaosheng Ren
Boxuan Du
Xian Liu
Yuqiu An
Peichi Zhang
Lexi Li
Zhenhong Liu
Kegang Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1452614

1,329 views

Review

Published on 07 Jan 2025

Mechanistic insight of curcumin: a potential pharmacological candidate for epilepsy

in Neuropharmacology

Saima Khatoon
Nida Kalam

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1531288

1,246 views
1 citation